• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

This product is currently not available for purchase.



  • ID: 1901632
  • September 2010
  • Region: Nigeria
  • 112 Pages
  • VDM Publishing House

This single-centre study was designed to assess the impact of a pharmaceutical care program in a Nigerian pharmacy. Patients underwent 5 months of usual care and another 5 months of pharmaceutical care. During pharmaceutical care intervention, patients received a face-to-face, goal-directed medication and lifestyle counselling once a month. Blood pressure and quality of life measured before implementation of pharmaceutical care and at the end served as main outcome measures. Other outcomes were also assessed. Twenty four (24) patients out of the 40 recruited completed the study. There were significant reductions in the mean values for systolic blood pressure (14.3 mmHg), diastolic blood pressure (10.8 mmHg) and alcohol misuse (33.3%) after pharmaceutical care intervention. There was a positive increase of -11.4 and -3.2 for physical health and social health domain of quality of life evaluation respectively. Pharmaceutical care programme for hypertensive patients provided in a Nigerian community pharmacy produced beneficial reduction in blood pressure and improved the health related quality of life of the patients.

Note: Product cover images may vary from those shown

Obinna, Ekwunife.
Obinna Ikechukwu Ekwunife, is a lecturer in the Department of Clinical Pharmacy and Pharmacy Management, University of Nigeria. Obinna has four years teaching experience in Pharmacotherapeutics and he researches on pharmacoeconomics and outcome research.

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

Our Clients

AB Sciex Eli Lilly and Company B. Braun Melsungen AG Astellas Pharma, Inc. Hologic Corporation Merck & Co., Inc.